Nucleosides

Polyoxorim is a fatty acid that has been synthesized by in vitro methods. It is a crystalline compound with three polymorphs, which are stable at different temperatures. Polyoxorim has been shown to have activity against human pathogens, including Mycobacterium tuberculosis and Candida albicans. The cytosolic protein of these microbes binds to the fatty acid and disrupts the cell membrane, causing leakage of intracellular materials and cell death. Polyoxorim has also been used in vitro assays to determine the optimum pH for bacterial growth.

2,2’-Anhydro-5-methyluridine-3’-CE phosphoramidite is a monophosphate nucleotide that is used as a building block for DNA synthesis. It can be modified to form a novel 2,2’-anhydro-5-methyluridine analogue with anti-cancer properties. This product also has antiviral and activator activities.

5-Cyanouridine is a pyrimidine nucleoside that is synthesized from uracil. It is a potent inhibitor of the enzyme decarboxylase, which catalyzes the conversion of 5-cytosine to 5-uracil, and has been used for the treatment of malignant lymphoma. 5-Cyanouridine is also a substrate for DNA replication and can be used as a target for antiviral drugs. The drug inhibits viral RNA synthesis by acting on the vesicular stomatitis virus (VSV) in two different ways: first, by inhibiting viral RNA polymerase activity; second, by incorporation into viral DNA. This incorporation can lead to chain termination or to translesion synthesis. 5-Cyanouridine has been shown to inhibit VSV replication in cell culture at concentrations as low as 1 μM.

2'-O-tert-Butyldimethylsilyl-N2-DMF-5'-O-DMT-guanosine 3'-CE phosphoramidite is a nucleoside monophosphate with CAS No. 58822-52-3. It is an activator that has anticancer and antiviral properties. This product is modified, novel and high purity and quality. 2'-O-tert-Butyldimethylsilyl-N2-DMF-5'-O-DMT-guanosine 3'-CE phosphoramidite can be used in the synthesis of oligonucleotides for use as probes or drugs in the treatment of cancer, HIV, hepatitis B and influenza A.

N6-Benzoyl-2'-O-benzyl-5'-O-DMT-adenosine is a novel nucleoside with anticancer and antiviral properties. It is a phosphoramidite that can be used for the synthesis of DNA, RNA, and other nucleosides. N6-Benzoyl-2'-O-benzyl-5'-O-DMT-adenosine has been shown to inhibit the growth of cancer cells by preventing RNA synthesis and DNA replication. This chemical also has antiviral effects against HIV and can inhibit the replication of herpes simplex virus type 1. The chemical is highly soluble in water, methanol, ethanol, acetone, chloroform, ethyl ether and acetonitrile.

N6-Benzoyl-7-deaza-2'-deoxyadenosine is a novel synthetic monophosphate activator that can be used to induce cell death in cancer cells. It is structurally similar to the natural nucleotide adenosine, and it binds to the same receptors on cells as adenosine. N6-Benzoyl-7-deaza-2'-deoxyadenosine has been shown to inhibit viral replication by interfering with DNA synthesis and RNA transcription, which are essential for viral reproduction.

N4-Benzoyl-2-aza-3’-deazaadenine is a modified nucleoside that is synthesized from the natural deoxyribonucleoside adenine. It has been shown to have antiviral and anticancer properties. N4-Benzoyl-2-aza-3’-deazaadenine is a DNA Activator and can be used in the treatment of viral infections, such as HIV and herpes, as well as cancer. The drug binds to the viral DNA polymerase and prevents it from making new copies of the virus. This results in an accumulation of defective viruses within infected cells and ultimately cell death.

8-Oxoguanosine monophosphate (8-oxoGMP) is a synthetic nucleoside that is activated by the enzyme thioredoxin reductase and phosphorylated to form 8-oxoGTP. The anticancer activity of 8-oxoGMP is due to its ability to inhibit ribonucleotide reductase, which reduces the production of DNA and RNA in cells. This product has been shown to inhibit HIV replication in vitro and in vivo. It also inhibits viral replication by inhibiting the synthesis of viral nucleic acids such as DNA, RNA, and deoxyribonucleic acid (DNA).

5'-O-DMT-2'-O-propylphthalimidouridine is a synthetic nucleoside that has antiviral and anticancer properties. It is used as a precursor for the synthesis of other nucleosides, including uridine and cytidine. 5'-O-DMT-2'-O-propylphthalimidouridine can be modified with phosphoramidites to create novel modified nucleosides. The chemical name is 1-(5'-O-dimethoxytrityl)-2-[(2' -propyl)thio]uracil. This drug has CAS number 61381-14-4 and molecular weight of 271.11 g/mol.

Please enquire for more information about 3'-Deoxy-3'-fluorocytidine including the price, delivery time and more detailed product information at the technical inquiry form on this page

9-(2'-Deoxy-2'-fluoro-b-D-arabinofuranosyl)guanine is a nucleoside phosphorylase inhibitor that is used to treat inflammatory bowel disease. It has been shown to be effective in treating women with inflammatory bowel disease, and has no significant side effects. 9-(2'-Deoxy-2'-fluoro-b-D-arabinofuranosyl)guanine inhibits the bacterial enzyme nucleoside phosphorylase, which is responsible for the conversion of guanosine triphosphate (GTP) to guanosine diphosphate (GDP). This inhibition prevents the synthesis of DNA and RNA by blocking the conversion of GTP and GDP into AMP and GMP. The drug binds to the active site of nucleoside phosphorylase, which is located in the bacterial cytoplasmic membrane. 9-(2'-Deoxy-2'-fluoro

N4-Acetyl-1-(2'-O-acetyl-5'-O-DMT-b-D-arabinofuranosyl)cytosine 3'-CE phosphoramidite is a novel nucleoside designed for DNA activation. It has high quality and high purity, which are essential for pharmaceutical and analytical applications. This product is used in the synthesis of DNA, antiviral drugs, and anti-cancer agents. N4-Acetyl-1-(2'-O-acetyl-5'-O-DMT b -D -arabinofuranosyl)cytosine 3'-CE phosphoramidite can be used as an activator in the synthesis of deoxyribonucleosides and ribonucleosides.

2-Amino-9-(2',3',5'-tri-O-acetyl-b-D-ribofuranosyl)purine is a novel nucleoside with anticancer and antiviral properties. It has been shown to inhibit replication of human immunodeficiency virus and herpes simplex virus type 1 in vitro. The drug also inhibits the growth of tumor cells in vitro. 2-Amino-9-(2',3',5'-tri-O-acetyl-b-D-ribofuranosyl)purine is an analog of adenosine, which is phosphorylated by the enzyme ribonucleoside diphosphate kinase to form 2'-deoxyadenosine monophosphate, a common building block for DNA synthesis.

3-Cyanovinylcarbazole phosphoramidite is a novel compound that has not been previously described. It is a deoxyribonucleoside monophosphate and can be used as an anticancer agent. 3-Cyanovinylcarbazole phosphoramidite is also an antiviral, which can inhibit the synthesis of viral DNA. The modified nucleosides in this compound are synthesized by modifying the ribonucleotide with a cyanovinyl group at the C-3 position, which can be used as phosphoramidites for DNA synthesis.

4'-C-Fluoroadenosine is a fluorine-substituted analog of adenosine, which has been shown to have minimal toxicity in animals. 4'-C-Fluoroadenosine inhibits the uptake of trypanosomes by macrophages and has been shown to be effective in treating Leishmania donovani infections in mice. Its mechanism of action is not yet clear, but it may involve inhibiting the enzymatic activity of enzymes involved in the metabolism of adenosine and/or enhancing the activity of those that are involved in catalysing adenoside triphosphate synthesis.

N4-Acetyl-2'-deoxy-5'-O-tritylcytidine is a novel nucleoside that is synthesized by modifying cytidine to form an acetylated nucleotide. It has been found to be an effective inhibitor of DNA synthesis and antiviral agent.

5'-Carboxy-2',3'-O-isopropylideneadenosine is a novel deoxyribonucleoside. It has high purity and high quality, good stability, and a low price. This product can be used as the raw material for synthesis of DNA, RNA, and phosphoramidites. It is an anticancer drug and antiviral agent that can be used to synthesize new drugs. It also has strong anti-inflammatory properties.

5’-O-DMT-2’-O-methoxyethyluridine is a novel phosphoramidite monophosphate, which can be used for the synthesis of DNA and RNA. This monophosphate is synthesized by reacting 5’-O-dimethoxytritylthymidine with 2’-O-methoxyethylchloride to produce a modified nucleoside. The modification of this nucleoside leads to improved stability against degradation and increased resistance to nucleases. It has been shown that 5’-O-DMT-2’-O-methoxyethyluridine has antiviral activity against Herpes Simplex Virus type 1 (HSV1) and other viruses in vitro.

5'-Deoxy-5-fluorouridine (5FU) is a nucleoside that is used in the treatment of cancer. It is an antimetabolite that inhibits the synthesis of DNA, RNA, and proteins by reversibly inhibiting ribonucleotide reductase. 5FU also inhibits epidermal growth factor receptor (EGFR), which leads to apoptosis in cancerous cells. The concentration-time curve for 5FU has been determined using tissue culture and hl-60 cells as biological samples. This drug has been shown to be effective against metastatic colorectal cancer when administered with other chemotherapeutic drugs.

5-Bromo-2'-deoxy-5'-O-DMT-uridine 3'-CE phosphoramidite is a nucleoside analog and a potential anticancer drug. It is an excellent monophosphate, which can be used as a building block for synthesis of DNA. 5-Bromo-2'-deoxy-5'-O-DMT-uridine 3'-CE phosphoramidite has antiviral activity against HIV and herpes simplex virus, as well as antifungal activity against Candida albicans. This compound has also been shown to have antitumor activity in vitro in the presence of other anticancer drugs.